Zomedica (NYSEMKT: ZOM)
Zomedica Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zomedica Company Info
Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.
News & Analysis
2 Meme Stocks That Are Still Down 50% Since February 2021
Don't jump on these bandwagons unless you're willing to lose most of your money.
2 Meme Stocks Investors Should Avoid at All Costs
These stocks are full of risk and losses are likely to mount in the future.
Zomedica Stock Jumped Today. Is It a Buy?
There's some reason for cautious optimism.
Why Zomedica Stock Is Soaring Today
Investors liked the company's fourth-quarter revenue growth.
Why Zomedica Stock Soared 72.4% This Week
The veterinary diagnostics company didn't see its shares jump until a spike on Thursday.
Why Shares of Zomedica Corp. Dropped 22.5% in December
The veterinary diagnostics company has been a volatile stock.
3 Rookie Mistakes to Avoid Making in the Stock Market
Now is a time to exercise more caution when picking stocks.
Why Zomedica Stock Is Sinking This Week
The downward momentum from last week's Q3 update continues.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.